Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Cheryl Warren, M.D.
Family Practice · SALADO, TX · NPI 1770549172
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 565 | 160 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 259 | 42 |
| Atorvastatin Calcium | Atorvastatin Calcium | 254 | 86 |
| Lisinopril | Lisinopril | 245 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 230 | 65 |
| Gabapentin | Gabapentin | 228 | 74 |
| Losartan Potassium | Losartan Potassium | 198 | 64 |
| Simvastatin | Simvastatin | 198 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 195 | 65 |
| Meloxicam | Meloxicam | 166 | 54 |
| Amlodipine Besylate | Amlodipine Besylate | 156 | 50 |
| Metformin Hcl Er | Metformin Hcl | 138 | 42 |
| Omeprazole | Omeprazole | 129 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 123 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 117 | 36 |
| Tramadol Hcl | Tramadol Hcl | 117 | 33 |
| Trazodone Hcl | Trazodone Hcl | 115 | 32 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 113 | 42 |
| Ozempic | Semaglutide | 107 | 18 |
| Sertraline Hcl | Sertraline Hcl | 105 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 98 | 27 |
| Spironolactone | Spironolactone | 98 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 33 |
| Pregabalin | Pregabalin | 88 | 20 |
| Alprazolam | Alprazolam | 86 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 31 |
| Montelukast Sodium | Montelukast Sodium | 82 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 82 | 26 |
| Eliquis | Apixaban | 79 | 20 |
| Finasteride | Finasteride | 77 | 18 |
| Metformin Hcl | Metformin Hcl | 75 | 21 |
| Alendronate Sodium | Alendronate Sodium | 74 | 20 |
| Estradiol | Estradiol | 71 | 24 |
| Potassium Chloride | Potassium Chloride | 70 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 63 | 20 |
| Atenolol | Atenolol | 62 | 15 |
| Furosemide | Furosemide | 61 | 22 |
| Glimepiride | Glimepiride | 61 | 19 |
| Mirtazapine | Mirtazapine | 61 | 16 |
| Prednisone | Prednisone | 61 | 30 |
| Celecoxib | Celecoxib | 60 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 58 | 14 |
| Allopurinol | Allopurinol | 56 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 54 | 18 |
| Solifenacin Succinate | Solifenacin Succinate | 54 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 53 | suppressed |
| Felodipine Er | Felodipine | 51 | 13 |
| Azithromycin | Azithromycin | 47 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 46 | 22 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 43 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 43 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 43 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | 14 |
| Jardiance | Empagliflozin | 40 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 35 |
| Clonazepam | Clonazepam | 39 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 39 | 13 |
| Donepezil Hcl | Donepezil Hcl | 39 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | 16 |
| Famotidine | Famotidine | 38 | suppressed |
| Lorazepam | Lorazepam | 38 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 38 | 17 |
| Carvedilol | Carvedilol | 37 | 15 |
| Bupropion Xl | Bupropion Hcl | 36 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 36 | 13 |
| Carisoprodol | Carisoprodol | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 35 | 12 |
| Mounjaro | Tirzepatide | 35 | suppressed |
| Ibuprofen | Ibuprofen | 34 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 16 |
| Nortriptyline Hcl | Nortriptyline Hcl | 32 | suppressed |
| Baclofen | Baclofen | 31 | suppressed |
| Fluconazole | Fluconazole | 31 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 25 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 28 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Lactulose | Lactulose | 27 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Cephalexin | Cephalexin | 24 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Torsemide | Torsemide | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 21 | 14 |
| Terbinafine Hcl | Terbinafine Hcl | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 15 |
| Topiramate | Topiramate | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 12 | suppressed |
| Constulose | Lactulose | 12 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Mesalamine Er | Mesalamine | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error